2018 and Beyond: New Zealand Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in New Zealand witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in New Zealand and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on New Zealand healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the New Zealand healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of New Zealand pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in New Zealand and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on New Zealand healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the New Zealand healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of New Zealand pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 New Zealand Pharmaceutical and Healthcare Industry Snapshot
2.2 New Zealand Pharmaceuticals Market Overview
3 NEW ZEALAND PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in New Zealand
3.2 Drivers and Restraints
3.2.1 Market Drivers in New Zealand Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in New Zealand Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 NEW ZEALAND PHARMACEUTICAL MARKET OUTLOOK
4.1 New Zealand Pharmaceutical Sales, $ Million, 2015- 2025
4.2 New Zealand Pharmaceutical Exports, $ million, 2015- 2025
4.3 New Zealand Pharmaceutical Imports, $ Million, 2015- 2025
4.4 New Zealand (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 New Zealand (% contribution) to Global Pharmaceutical Market size, 2017
4.6 New Zealand Prescription Drug Sales, $ Million, 2015- 2025
4.7 New Zealand Generic Drug Sales, $ Million, 2015- 2025
5 NEW ZEALAND HEALTHCARE MARKET OUTLOOK
5.1 New Zealand Healthcare Expenditure Outlook, 2015- 2025
5.2 New Zealand Healthcare Expenditure (% of GDP), 2015- 2025
5.3 New Zealand Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 New Zealand Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in New Zealand, 2015- 2025
6 NEW ZEALAND HEALTHCARE MARKET STATISTICS
6.1 New Zealand Mortality by Disease Category, 2017
6.2 Number of Hospitals in New Zealand, 2007- 2017
6.3 Number of Hospital Beds in New Zealand, 2007- 2017
6.4 Physicians Count in New Zealand, 2007- 2017
6.5 Pharmacists Count in New Zealand, 2007- 2017
7 NEW ZEALAND CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in New Zealand, 2017
7.2 Ongoing Clinical Trials by Disease Category in New Zealand, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 NEW ZEALAND DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 New Zealand Population Forecast by Age Group, 2005- 2025
8.2 New Zealand Population Forecast by Location, 2005- 2025
8.3 New Zealand GDP Forecast, 2005- 2025
8.4 New Zealand GDP Per Capita Forecast, 2005- 2025
8.5 New Zealand Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN NEW ZEALAND PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 New Zealand Pharmaceutical and Healthcare Industry Snapshot
2.2 New Zealand Pharmaceuticals Market Overview
3 NEW ZEALAND PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in New Zealand
3.2 Drivers and Restraints
3.2.1 Market Drivers in New Zealand Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in New Zealand Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 NEW ZEALAND PHARMACEUTICAL MARKET OUTLOOK
4.1 New Zealand Pharmaceutical Sales, $ Million, 2015- 2025
4.2 New Zealand Pharmaceutical Exports, $ million, 2015- 2025
4.3 New Zealand Pharmaceutical Imports, $ Million, 2015- 2025
4.4 New Zealand (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 New Zealand (% contribution) to Global Pharmaceutical Market size, 2017
4.6 New Zealand Prescription Drug Sales, $ Million, 2015- 2025
4.7 New Zealand Generic Drug Sales, $ Million, 2015- 2025
5 NEW ZEALAND HEALTHCARE MARKET OUTLOOK
5.1 New Zealand Healthcare Expenditure Outlook, 2015- 2025
5.2 New Zealand Healthcare Expenditure (% of GDP), 2015- 2025
5.3 New Zealand Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 New Zealand Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in New Zealand, 2015- 2025
6 NEW ZEALAND HEALTHCARE MARKET STATISTICS
6.1 New Zealand Mortality by Disease Category, 2017
6.2 Number of Hospitals in New Zealand, 2007- 2017
6.3 Number of Hospital Beds in New Zealand, 2007- 2017
6.4 Physicians Count in New Zealand, 2007- 2017
6.5 Pharmacists Count in New Zealand, 2007- 2017
7 NEW ZEALAND CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in New Zealand, 2017
7.2 Ongoing Clinical Trials by Disease Category in New Zealand, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 NEW ZEALAND DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 New Zealand Population Forecast by Age Group, 2005- 2025
8.2 New Zealand Population Forecast by Location, 2005- 2025
8.3 New Zealand GDP Forecast, 2005- 2025
8.4 New Zealand GDP Per Capita Forecast, 2005- 2025
8.5 New Zealand Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN NEW ZEALAND PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
